Blood pressure goal in chronic kidney disease: what is the evidence?
- 1 May 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Nephrology and Hypertension
- Vol. 20 (3), 229-232
- https://doi.org/10.1097/mnh.0b013e3283454332
Abstract
Most guidelines recommend that seated clinic blood pressure (BP) be targeted to less than 130/80 mmHg in patients with chronic kidney disease (CKD). The evidence underlying these recommendations is the subject of this review. The best evidence to target a certain level of BP in patients with CKD comes from randomized trials. Only three trials have prospectively examined the level to which BP should be lowered. These trials conducted exclusively among patients with CKD have demonstrated that compared to a less aggressive BP goal, a BP goal of less than 130/80 mmHg neither saves lives nor protects the kidney or the cardiovascular system. It is reasonable to achieve a goal of less than 140/90 mmHg in most patients with CKD. More aggressive lowering is not firmly supported by current data. Since BP control is important, hypertension therapy should be individualized. Individualization through home BP measurements to diagnose, monitor and treat hypertension appears to be an attractive option.Keywords
This publication has 13 references indexed in Scilit:
- Cardiovascular Protection With Antihypertensive Drugs in Dialysis PatientsHypertension, 2009
- Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trialsThe Lancet, 2009
- Masked Hypertension and White-Coat Hypertension in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Blood Pressure Recordings within and outside the Clinic and Cardiovascular Events in Chronic Kidney DiseaseAmerican Journal of Nephrology, 2006
- Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trialThe Lancet, 2005
- Hypertension and survival in chronic hemodialysis patients—Past lessons and future opportunitiesKidney International, 2005
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJama-Journal Of The American Medical Association, 2003
- Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney DiseaseResults From the AASK TrialJama-Journal Of The American Medical Association, 2002
- Blood Pressure Control, Proteinuria, and the Progression of Renal DiseaseAnnals of Internal Medicine, 1995
- The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal DiseaseNew England Journal of Medicine, 1994